Costs of Telaprevir-based Triple Therapy for Hepatitis C: $189,000 per Sustained Virologic Response

INTRODUCTION: In registration trials, triple therapy with telaprevir (TVR), pegylated-interferon (IFN), and ribavirin (RBV) achieved sustained virological response (SVR) rates between 64–75%, but the clinical effectiveness and economic burdens of this treatment in real-world practice remain to be de...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bichoupan, Kian, Martel-Laferriere, Valerie, Sachs, David, Ng, Michel, Schonfeld, Emily A., Pappas, Alexis, Crismale, James, Stivala, Alicia, Khaitova, Viktoriya, Gardenier, Donald, Linderman, Michael, Perumalswami, Ponni V., Schiano, Thomas D., Odin, Joseph A., Liu, Lawrence, Moskowitz, Alan J., Dieterich, Douglas T., Branch, Andrea D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4190678/
https://ncbi.nlm.nih.gov/pubmed/25065814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27340
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak